S&P 500   3,604.06 (-0.94%)
DOW   29,502.24 (-1.36%)
QQQ   297.41 (-0.54%)
AAPL   118.87 (+1.96%)
MSFT   211.85 (-1.57%)
FB   273.43 (-1.58%)
GOOGL   1,752.22 (-1.95%)
AMZN   3,145.72 (-1.55%)
TSLA   587.18 (+0.24%)
NVDA   526.18 (-0.80%)
BABA   265.56 (-3.95%)
CGC   28.55 (-1.55%)
GE   10.26 (-1.35%)
MU   64.67 (+0.69%)
AMD   90.25 (+3.51%)
T   28.88 (-0.52%)
NIO   51.83 (-4.02%)
F   9.12 (+0.33%)
ACB   10.92 (+4.30%)
NFLX   485.93 (-1.11%)
BA   211.90 (-2.12%)
GILD   59.80 (-0.38%)
DIS   147.45 (+0.22%)
S&P 500   3,604.06 (-0.94%)
DOW   29,502.24 (-1.36%)
QQQ   297.41 (-0.54%)
AAPL   118.87 (+1.96%)
MSFT   211.85 (-1.57%)
FB   273.43 (-1.58%)
GOOGL   1,752.22 (-1.95%)
AMZN   3,145.72 (-1.55%)
TSLA   587.18 (+0.24%)
NVDA   526.18 (-0.80%)
BABA   265.56 (-3.95%)
CGC   28.55 (-1.55%)
GE   10.26 (-1.35%)
MU   64.67 (+0.69%)
AMD   90.25 (+3.51%)
T   28.88 (-0.52%)
NIO   51.83 (-4.02%)
F   9.12 (+0.33%)
ACB   10.92 (+4.30%)
NFLX   485.93 (-1.11%)
BA   211.90 (-2.12%)
GILD   59.80 (-0.38%)
DIS   147.45 (+0.22%)
S&P 500   3,604.06 (-0.94%)
DOW   29,502.24 (-1.36%)
QQQ   297.41 (-0.54%)
AAPL   118.87 (+1.96%)
MSFT   211.85 (-1.57%)
FB   273.43 (-1.58%)
GOOGL   1,752.22 (-1.95%)
AMZN   3,145.72 (-1.55%)
TSLA   587.18 (+0.24%)
NVDA   526.18 (-0.80%)
BABA   265.56 (-3.95%)
CGC   28.55 (-1.55%)
GE   10.26 (-1.35%)
MU   64.67 (+0.69%)
AMD   90.25 (+3.51%)
T   28.88 (-0.52%)
NIO   51.83 (-4.02%)
F   9.12 (+0.33%)
ACB   10.92 (+4.30%)
NFLX   485.93 (-1.11%)
BA   211.90 (-2.12%)
GILD   59.80 (-0.38%)
DIS   147.45 (+0.22%)
S&P 500   3,604.06 (-0.94%)
DOW   29,502.24 (-1.36%)
QQQ   297.41 (-0.54%)
AAPL   118.87 (+1.96%)
MSFT   211.85 (-1.57%)
FB   273.43 (-1.58%)
GOOGL   1,752.22 (-1.95%)
AMZN   3,145.72 (-1.55%)
TSLA   587.18 (+0.24%)
NVDA   526.18 (-0.80%)
BABA   265.56 (-3.95%)
CGC   28.55 (-1.55%)
GE   10.26 (-1.35%)
MU   64.67 (+0.69%)
AMD   90.25 (+3.51%)
T   28.88 (-0.52%)
NIO   51.83 (-4.02%)
F   9.12 (+0.33%)
ACB   10.92 (+4.30%)
NFLX   485.93 (-1.11%)
BA   211.90 (-2.12%)
GILD   59.80 (-0.38%)
DIS   147.45 (+0.22%)
Log in
NASDAQ:TLRY

Tilray Stock Forecast, Price & News

$8.73
+0.23 (+2.71 %)
(As of 11/30/2020 11:52 AM ET)
Add
Compare
Today's Range
$8.08
Now: $8.73
$9.26
50-Day Range
$5.56
MA: $6.88
$10.10
52-Week Range
$2.43
Now: $8.73
$22.95
Volume634,096 shs
Average Volume10.21 million shs
Market Capitalization$1.17 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.02
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Read More
Tilray logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.97 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLRY
CUSIPN/A
CIKN/A
Phone206-432-9325
Employees1,646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$166.98 million
Book Value$2.78 per share

Profitability

Net Income$-321,170,000.00
Net Margins-259.60%

Miscellaneous

Market Cap$1.17 billion
Next Earnings Date3/1/2021 (Estimated)
OptionableOptionable
$8.73
+0.23 (+2.71 %)
(As of 11/30/2020 11:52 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLRY News and Ratings via Email

Sign-up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tilray (NASDAQ:TLRY) Frequently Asked Questions

How has Tilray's stock been impacted by Coronavirus (COVID-19)?

Tilray's stock was trading at $7.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLRY stock has increased by 21.3% and is now trading at $8.60.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Tilray?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 3 sell ratings, 10 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Tilray
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Tilray?

Wall Street analysts have given Tilray a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tilray wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for Tilray
.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.19. The company had revenue of $51.41 million for the quarter, compared to the consensus estimate of $54.91 million. Tilray had a negative return on equity of 77.77% and a negative net margin of 259.60%. The company's revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.36) EPS.
View Tilray's earnings history
.

What price target have analysts set for TLRY?

14 brokers have issued 1-year price targets for Tilray's shares. Their forecasts range from $4.00 to $20.00. On average, they anticipate Tilray's stock price to reach $10.95 in the next year. This suggests a possible upside of 27.3% from the stock's current price.
View analysts' price targets for Tilray
.

Are investors shorting Tilray?

Tilray saw a increase in short interest in October. As of October 15th, there was short interest totaling 27,590,000 shares, an increase of 15.8% from the September 30th total of 23,830,000 shares. Based on an average daily trading volume, of 7,210,000 shares, the short-interest ratio is currently 3.8 days.
View Tilray's Short Interest
.

Who are some of Tilray's key competitors?

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Square (SQ).

Who are Tilray's key executives?

Tilray's management team includes the following people:
  • Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
  • Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
  • Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
  • Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board

When did Tilray IPO?

(TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.17%), Princeton Global Asset Management LLC (0.11%), Freestone Capital Holdings LLC (0.09%), LPL Financial LLC (0.04%), Cubist Systematic Strategies LLC (0.03%) and Garde Capital Inc. (0.03%). Company insiders that own Tilray stock include Brendan Kennedy, Christine StClare, Edward Wood Pastorius Jr, Mark Castaneda, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends for Tilray
.

Which institutional investors are selling Tilray stock?

TLRY stock was sold by a variety of institutional investors in the last quarter, including Princeton Global Asset Management LLC, Freestone Capital Holdings LLC, and FinTrust Capital Advisors LLC. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, Christine StClare, Maryscott Greenwood, and Michael Auerbach.
View insider buying and selling activity for Tilray
.

Which institutional investors are buying Tilray stock?

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Cubist Systematic Strategies LLC, LPL Financial LLC, Garde Capital Inc., California Public Employees Retirement System, National Asset Management Inc., Raymond James & Associates, Cambria Investment Management L.P., and AdvisorShares Investments LLC.
View insider buying and selling activity for Tilray
.

How do I buy shares of Tilray?

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $8.60.

How big of a company is Tilray?

Tilray has a market capitalization of $1.15 billion and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe.

What is Tilray's official website?

The official website for Tilray is www.tilray.com.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.